The products are far from a proven sleep treatment.
A new randomized clinical trial from investigators at Mass General Brigham’s Neuroscience Institute and Department of ...
US Health and Human Services Secretary Robert F. Kennedy Jr. attacks scientific literature with censorship to push MAHA ...
Postbiotics are gaining momentum. How can ingredient branding support the accessibility of postbiotics in F&B applications?
Morning Overview on MSNOpinion
A once-a-day pill nearly doubled survival for patients with advanced pancreatic cancer in a 500-person trial
Patients with previously treated metastatic pancreatic cancer lived roughly twice as long when given an oral pill called ...
A new randomized clinical trial from investigators at Mass General Brigham's Neuroscience Institute and Department of ...
In two analyses, Noom members were modeled to gain less than 2% of bodyweight up to 12 months after stopping medication — ...
After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo ...
The prevalence of overweight and obesity represents a global public health challenge 1. Incretin mimetic therapies, including glucagon-like peptide 1 (GLP-1) receptor agonists and dual ...
A new randomized clinical trial from investigators at Mass General Brigham's Neuroscience Institute and Department of Psychiatry suggests that using personalized brain imaging to guide transcranial ...
High-dose DHA effectively increased brain levels in older adults at Alzheimer's risk, but did not lead to cognitive or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results